“Long-term Outcomes of Fixed-Combination Halobetasol Propionate and Tazarotene Lotion Stratified by Baseline Signs and Symptoms of Psoriasis”, J of Skin, vol. 5, no. 6, p. s49, Nov. 2021, doi: 10.25251/skin.5.supp.49.